Search

Your search for 'medicinering' returned 257 results
Fess search
  1. Individualiserad medicin främjar hälsa och välfärd Individualiserad medicin främjar individens hälsa och välfärd genom utnyttjande av forskning, ny teknik och större informationsresurser än tidigare. Målet är att förebygga sjukdomar och förbättra ...
    https://stm.fi/sv/individualiserad-medicin
  2. fi sv en Personalised medicine creates preconditions for more effective treatment Personalised medicine promotes the health and wellbeing of individuals by utilising research, new technologies and a wider range of information resources. The aim is...
    https://stm.fi/en/personalized-medicine
  3. Biotechnology and Medicines Unit (BILA) - personnel Hidden
    https://stm.fi/en/bila-personnel
  4. Project on medicines and financial base of pharmacies The Government Programme includes numerous entries related to medicines and pharmacies. These entries will be implemented in a project titled ‘Medicines and the financial base of pharmacies’ in...
    https://stm.fi/en/reform-of-pharmaceutical-matters
  5. 1.12.2025 | The EU ministers will attend the Employment, Social Policy, Health and Consumer Affairs Council in Brussels on 1 and 2 December 2025. On both days, Finland will be represented by Minister of Social Affairs and Health Kaisa Juuso.
    https://stm.fi/en/-/eu-ministers-to-discuss-carcinogens-and-mutagens-directive-critical-medicines-simplification-of-legislation-and-european-globalisation-adjustment-fund
  6. 23.4.2024 | The health ministers of the EU Member States will discuss the availability of healthcare personnel and medicines at their informal meeting in Brussels on 23–24 April. 
    https://stm.fi/en/-/eu-ministerial-meeting-on-healthcare-personnel-and-medicine-availability
  7. 3.10.2024 | According to a working group appointed by the Ministry of Social Affairs and Health, the sale of some over-the-counter medicines could be expanded outside pharmacies if the change is made in a controlled manner, ensuring medication safety. The change could improve the availability of over-the-counter medicines and reduce the costs of medicines for consumers and society.
    https://stm.fi/en/-/working-group-the-sale-of-over-the-counter-medicines-outside-pharmacies-should-be-implemented-in-a-controlled-and-systematic-manner
  8. 3.5.2023 | An informal meeting of EU employment and social affairs ministers will take place in Stockholm on 3–4 May 2023 and an informal meeting of EU health ministers on 4–5 May 2023. Minister of Social Affairs and Health Hanna Sarkkinen and Minister of Family Affairs and Social Services Krista Kiuru will represent Finland at the meetings.
    https://stm.fi/en/-/eu-ministers-meet-to-discuss-access-to-medicinal-products-skills-in-working-life-and-eu-social-dimension-
  9. 29.11.2023 | At the beginning of 2023, an amendment to the Decree on Prescribing Medicines entered into force whereby prescriptions for all biological medicines are valid for one year. People using biological medicines should check the validity of their prescriptions with their attending physician or the pharmacy.
    https://stm.fi/en/-/prescriptions-for-biological-medicines-are-only-valid-for-one-year-at-a-time
  10. 30.11.2023 | The EU health ministers will meet in Brussels on Thursday 30 November 2023. The ministers will exchange views on safeguarding the EU’s open strategic autonomy in the field of health, particularly on how to ensure the availability of medicines in Europe. They will also approve conclusions on mental health. Minister of Social Security Sanni Grahn-Laasonen will represent Finland at the meeting.
    https://stm.fi/en/-/eu-health-ministers-to-discuss-steps-to-ensure-access-to-medicines-
  11. According to the Ministry of Social Affairs and Health Decree on the prescription of medicines (1088/2010), special attention must be given to the safety of pharmaceuticals.
    https://stm.fi/en/legislation-steering-and-supervision-cooperation
  12. Value chain for pharmacotherapy Pharmaceuticals-related development, research and innovations The facilitation of research and development of pharmaceuticals is a requirement for new pharmaceutical innovations. It is characteristic of the pharmace...
    https://stm.fi/en/value-chain-for-pharmacotherapy
  13. Rational, or sensible, pharmacotherapy is effective, safe, of high quality, economical and equal.
    https://stm.fi/en/rational-pharmacotherapy
  14. Pharmacotherapy and pharmaceutical service The Ministry of Social Affairs and Health is responsible for the development of pharmaceutical services and for preparation of legislation on pharmaceuticals. Pharmaceutical services are an integral part ...
    https://stm.fi/en/pharmacotherapy
  15. Safety of pharmacotherapy Pharmacotherapy is an integral part of comprehensive care. At its best, pharmacotherapy can cure illnesses, slow the progression of illnesses, reduce the symptoms of illnesses and prevent illnesses. Safe pharmacotherapy c...
    https://stm.fi/en/safety-of-pharmacotherapy
  16. Electronic services support the pharmacotherapy Medication list as a tool for healthcare professionals A national up-to-date medication list is under preparation. Its benefits will be based on a procedure where all essential structural medication ...
    https://stm.fi/en/rational-pharmacotherapy/digital-services
  17. Department for Safety, Security and Health The Department for Safety, Security and Health handles issues pertaining to: organising environmental healthcare and health protection alcohol, tobacco and drug policy and the prevention of harm caused by...
    https://stm.fi/en/department-for-safety-security-and-health
  18. Narcotics control The central framework for narcotics legislation in Finland is based on the Narcotics Act (373/2008). In the Narcotics Act two types of substances are defined that are listed in corresponding Government degrees. ‘Narcotics’ are li...
    https://stm.fi/en/narcotics-control
  19. 18.8.2020 | The Ministry of Social Affairs and Health has decided to temporarily restrict the sale and release for consumption of medicinal products containing paracetamol or dexamethasone. The restrictions will enter into force on 18 August 2020 and will remain in force until 15 January 2021.
    https://stm.fi/en/-/restrictions-on-the-sale-of-medicinal-products-containing-paracetamol-or-dexamethasone-to-ensure-their-availability-and-sufficiency
  20. Sickness and rehabilitation All people living in Finland are included within the scope of sickness insurance. Sickness insurance provides reimbursements for loss of earnings and costs of rehabilitation. Sickness (Kela) Sickness allowance Paid to 1...
    https://stm.fi/en/income-security/sickness-rehabilitation